Cargando…
Conformation specific antagonistic high affinity antibodies to the RON receptor kinase for imaging and therapy
The RON receptor tyrosine kinase is an exceptionally interesting target in oncology and immunology. It is not only overexpressed in a wide variety of tumors but also has been shown to be expressed on myeloid cells associated with tumor infiltration, where it serves to dampen tumour immune responses...
Autores principales: | Yu Koh, Xin, Koh, Xiao Hui, Spiegelberg, Diana, Jha, Preeti, Nestor, Marika, Hwang, Le-ann, Tan, Ban Xiong, Lane, David Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800565/ https://www.ncbi.nlm.nih.gov/pubmed/36581692 http://dx.doi.org/10.1038/s41598-022-26404-7 |
Ejemplares similares
-
Ron Knockdown and Ron Monoclonal Antibody IMC-RON8 Sensitize Pancreatic Cancer to Histone Deacetylase Inhibitors (HDACi)
por: Zou, Yi, et al.
Publicado: (2013) -
Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy
por: Mortensen, Anja C., et al.
Publicado: (2018) -
The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer Model
por: Spiegelberg, Diana, et al.
Publicado: (2020) -
Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates
por: Baker, Jillian G., et al.
Publicado: (2007) -
Autoinhibition of the Ron receptor tyrosine kinase by the juxtamembrane domain
por: Wang, Xin, et al.
Publicado: (2014)